Uterine artery embolization

More hysterectomies can be averted with earlier uterine artery embolization for postpartum hemorrhage

Retrieved on: 
Saturday, March 23, 2024
Health, Postpartum bleeding, Hysterectomy, Uterus, Internal bleeding, Uterine artery embolization, Incidence, Abdominal pain, Patient, Uncontrolled, Research, Bleeding, University, Society, Artery, Woman, Treatment, Blood, Birth control

FAIRFAX, Va., March 23, 2024 /PRNewswire/ -- Early intervention with a minimally invasive treatment called uterine artery embolization (UAE) can help women avoid hysterectomy due to severe bleeding after childbirth, according to a new study being presented at the Society of Interventional Radiology Annual Scientific Meeting in Salt Lake City.

Key Points: 
  • The study was a retrospective review of 66 patients (median age, 31) who underwent UAE for uncontrolled postpartum hemorrhage at a single, high-volume medical center between 2014 and 2022.
  • Postpartum hemorrhage is a rare but potentially deadly complication of childbirth.
  • The study found that it was more likely to occur in patients who experienced greater blood loss before embolization.
  • Abstract #189 : Short-Term and Long-Term Outcomes of Uterine Artery Embolization for Treatment of Uncontrolled Post-Partum Hemorrhage.

Uterine Fibroids Impact Up to 70% of African American Women Over the Age of 50

Retrieved on: 
Saturday, April 15, 2023
Pelvic pain, Advertising, Pregnancy, Bleeding, Wrist, Friends, Patient, Neoplasm, Urination, Quality of life, Constipation, Nutrient, Woman, Infertility, Research, Uterus, Weight gain, Precision, Pain, Blood, Fibroid, MD, Iron, National Institute for Health and Care Excellence, Risk, Physiology, Menstruation, Uterine fibroid, Uterine artery embolization, Personal lubricant, Hysterectomy, UFE, Groin, Family, Sand, Urinary incontinence, Birth control

San Diego, April 15, 2023 /PRNewswire-PRWeb/ -- Precision Therapy provides outpatient fibroid treatment in San Diego to host virtual event!

Key Points: 
  • Up to 40% of women over the age of 35 have uterine fibroids, and that number increases to over 70% of women over 50.
  • African American women are three times more likely to have fibroids than women of other ethnicities.
  • Up to 40% of women over the age of 35 have uterine fibroids, and that number increases to over 70% of women over 50.
  • African American women are three times more likely to have fibroids than women of other ethnicities.

SIR Foundation Receives Major Gift to Support Research Grants and Panel on Uterine Health

Retrieved on: 
Monday, March 6, 2023
MD, Physician, Society of Interventional Radiology, Uterine fibroid, UFE, Adenomyosis, Research, Uterine artery embolization, Woman, Patient, Collection, Society, SIR, Knowledge, Interventional radiology, Pharmaceutical industry, Medical device

PHOENIX, March 6, 2023 /PRNewswire/ -- The Society of Interventional Radiology (SIR) Foundation announced a major gift from John Lipman, MD, FSIR, of Atlanta, that will propel uterine fibroid research forward.

Key Points: 
  • PHOENIX, March 6, 2023 /PRNewswire/ -- The Society of Interventional Radiology (SIR) Foundation announced a major gift from John Lipman, MD, FSIR, of Atlanta, that will propel uterine fibroid research forward.
  • The announcement was made at the SIR Foundation Gala on March 5 during the SIR 2023 Annual Scientific Meeting.
  • The Dr. Scott C. Goodwin Uterine Artery Embolization Grant is focused on advancing uterine fibroid and uterine artery embolization research and will launch in October 2023.
  • Spies, MD, FSIR, are highly regarded pioneers of uterine fibroid research, having led the SIR Foundation's Fibroid Registry, the largest collection of data on uterine fibroids, and conducted foundational research into uterine artery embolization.

American Endovascular & Amputation Prevention LLC Transitions to eClinicalWorks to Eliminate Administrative Burden

Retrieved on: 
Wednesday, December 14, 2022
Technology, Health Technology, Software, Practice Management, Other Health, Internet, Health, General Health, Data Management, ENDO, Cloud, Moyamoya disease, Physician, EHR, Electronic health record, ESRD, PAE, PRISMA, Patient, 3D ultrasound, Prostatic artery embolization, Automation, Amputation, Multimedia, Uterine artery embolization, PAD, Ischemia, Practice management software, CLI, Database, Venous insufficiency, Robotic process automation, Medical imaging, Medicine

eClinicalWorks , the largest ambulatory cloud EHR, today announced that American Endovascular & Amputation Prevention LLC transitioned to eClinicalWorks multi-dimensional EHR solution.

Key Points: 
  • eClinicalWorks , the largest ambulatory cloud EHR, today announced that American Endovascular & Amputation Prevention LLC transitioned to eClinicalWorks multi-dimensional EHR solution.
  • This added administrative work for physicians and slowed down our practice workflows, said Deborah Helmer, COO of American Endovascular.
  • American Endovascular affiliated physicians are at the forefront of the battle to prolong life by preventing amputations.
  • The American Endovascular affiliated physicians are proud to offer high-quality, compassionate endovascular care for patients throughout New Jersey, New York, and Ohio.

AAGL to Offer an Extensive Lineup of Postgraduate and Continuing Medical Education Courses for the 50th Annual Global Congress on Minimally Invasive Gynecologic Surgery

Retrieved on: 
Friday, October 15, 2021
Linda, Mentorship, Division, AAGL, Department of Obstetrics and Gynecology (Massachusetts General Hospital), Scientific programming language, University of Texas at Austin, Hysteroscopy, Obstetrics, Sofie (surgical robot), University, Research, Travel, University of Naples Federico II, Pelvic pain, Assistant professor, Associate, Uterine fibroid, Hysterectomy, Department, Infertility, Woman, CME, Education, Radiology, Uterine artery embolization, PG, Fibroid, University of Rome Tor Vergata, Female, Culture, Mayo Clinic, Pathology, Reproductive surgery, Congress, Rock, Court of general sessions, Anorexia nervosa (differential diagnoses), Surgeon, Session, Radiofrequency ablation, Curriculum, Safety, Medicine, Medical device

The Scientific Program at AAGL annual meetings are always meticulously developed and are renowned for offering the best in MIGS education.

Key Points: 
  • The Scientific Program at AAGL annual meetings are always meticulously developed and are renowned for offering the best in MIGS education.
  • This year's curriculum will consist of PG Courses, Hands-on Surgical Labs, Plenary Sessions, Panels, Debates and Open Communication breakout sessions.
  • Premiering this year, AAGL is excited to introduce AAGL Talks, 15-minute TED-like presentations prior to the General Sessions, that will also provide CME credits.
  • AAGL is a professional medical association of laparoscopic surgeons and is the global leader in minimally invasive gynecologic surgery.

Black Women's Health Advocates Applaud Legislation to Address the Uterine Fibroid Crisis

Retrieved on: 
Friday, July 23, 2021
Anatomy, Gynaecological neoplasia, Uterine fibroid, Clinical medicine, Medicine, Uterus, Fibroid, Uterine artery embolization, Adenomyosis

"Uterine fibroids are a health threat that urgently requires research, resources, and improved treatment options."

Key Points: 
  • "Uterine fibroids are a health threat that urgently requires research, resources, and improved treatment options."
  • "Uterine fibroids are a health threat that urgently requires research, community resources, and improved treatment options that preserve fertility.
  • BWHI supports this legislation because it will increase funding for uterine fibroid research and lead to new evidence-based treatments and cures for women of color."
  • "There is much more work to be done to address the uterine fibroid crisis.

Global Uterine Fibroids Epidemiology and Patient Flow Research Report 2021: Prevalence, Diagnosed, and Drug-treated Patients to 2035 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 14, 2021
Health, Pharmaceutical, Benign neoplasms, Gynaecological neoplasia, Uterine fibroid, Clinical medicine, Medicine, Health, Uterine artery embolization

The "Global Uterine Fibroids Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Uterine Fibroids Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Global Uterine Fibroids Epidemiology and Patient Flow Analysis - 2021, provides Uterine Fibroids epidemiology, demographics, and patient flow.
  • The research provides population data to characterize Uterine Fibroids patients, history of the disease at the population level (Uterine Fibroids prevalence, Uterine Fibroids incidence) and at the clinical level (from diagnosis to treated patients).
  • Demographics: Uterine Fibroids patients by age group, gender
    The data from this research will help executives:
    Establish basis for Uterine Fibroids market sizing, assessing market potential, and developing drug forecast models
    Identify Uterine Fibroids patients segments through age groups, gender, and disease sub-types
    Evaluate Uterine Fibroids market opportunities, identify target patient population
    View source version on businesswire.com: https://www.businesswire.com/news/home/20210714005471/en/

Free From Fibroids Will Raise Awareness of all Available Treatment Options for Symptomatic Uterine Fibroids

Retrieved on: 
Wednesday, June 30, 2021
Gynaecological neoplasia, Uterine fibroid, Clinical medicine, Medicine, Health, Gynecological surgery, Surgical instruments, Uterine myomectomy, Uterine artery embolization

WASHINGTON , June 30, 2021 /PRNewswire-PRWeb/ -- Today, Free From Fibroids and the Fibroid Coalition officially launched their efforts to raise awareness of all available treatment options for uterine fibroids.

Key Points: 
  • WASHINGTON , June 30, 2021 /PRNewswire-PRWeb/ -- Today, Free From Fibroids and the Fibroid Coalition officially launched their efforts to raise awareness of all available treatment options for uterine fibroids.
  • They have assembled a group of individuals who are passionate about providing patients and physicians with non-surgical treatment options for fibroids.
  • Uterine fibroids are diagnosed roughly three times more frequently in Black women and women of color than in white women of the same age.
  • Free From Fibroids is dedicated to the following:
    To support and empower women suffering with uterine fibroids.

New Fibroid Management Guidance from the American College of Obstetricians and Gynecologists Supports Laparoscopic Radiofrequency Ablation (Lap-RFA) as a Minimally Invasive, Uterine Preserving Treatment Option

Retrieved on: 
Monday, May 24, 2021
Health, Medical devices, Consumer, Women, Surgery, General Health, Radiology, Medicine, Clinical medicine, Medical specialties, Interventional radiology, Surgical oncology, Gynaecological neoplasia, Uterine fibroid, Radiofrequency ablation, Ablation, Uterine artery embolization, Uterine myomectomy

Hologic, Inc. (Nasdaq: HOLX), a global leader in womens health, announced today that the American College of Obstetricians and Gynecologists (ACOG), in its updated guidance for Management of Symptomatic Uterine Leiomyomas , supports the use of laparoscopic radiofrequency ablation (Lap-RFA) for the treatment of uterine fibroids.

Key Points: 
  • Hologic, Inc. (Nasdaq: HOLX), a global leader in womens health, announced today that the American College of Obstetricians and Gynecologists (ACOG), in its updated guidance for Management of Symptomatic Uterine Leiomyomas , supports the use of laparoscopic radiofrequency ablation (Lap-RFA) for the treatment of uterine fibroids.
  • ACOGs updated guidance in Practice Bulletin Number 228 will help physicians and patients considering fibroid treatment recognize Lap-RFA as a safe and effective uterine sparing option.
  • The Acessa procedure provides a minimally invasive, uterine-sparing surgical option for women with symptomatic fibroids who would otherwise require more invasive intervention.
  • This treatment combines laparoscopic ultrasound with radiofrequency ablation to destroy fibroid tissue through coagulation necrosis.

Gynesonics Announces Publication of SAGE Global Registry Preliminary Results: Real-World Usage Corroborates the Safety and Applicability of Sonata Transcervical Fibroid Ablation

Retrieved on: 
Thursday, April 15, 2021
Medical devices, Women, Consumer, Health, Clinical trials, Gynaecological neoplasia, Uterine fibroid, Anatomy, Clinical medicine, Women's health, Medicine, Fibroid, Uterus, Uterine artery embolization, Sonata System, Gynesonics

Ablated fibroid diameters ranged from 10 cm, with 27 percent of fibroids having maximum diameters >5 cm.

Key Points: 
  • Ablated fibroid diameters ranged from 10 cm, with 27 percent of fibroids having maximum diameters >5 cm.
  • Additionally, the preliminary results indicated the Sonata System maintained its established safety profile with very low device-related adverse event and serious procedure-related adverse event rates of 0.6 percent for both measures.
  • No limitations are imposed on maximum patient age, fibroid type, fibroid size, prior surgical history, baseline symptom severity, or desire for future fertility.
  • Gynesonics has developed the Sonata System for diagnostic intrauterine imaging and transcervical treatment of symptomatic uterine fibroids.